US-Listed Public Company Profile built from SEC and market records · June 2026

DEXCOM INC (DXCM)

$78.57 +0.81% NASDAQ: DXCM · 15-min delayed

SAN DIEGO, California
Public · NASDAQ: DXCM
11,100 employees

Visit website Follow

$27.6BMarket cap

$4.7BRevenue · FY2025

$836.3MNet income

11,100Employees

DXCMNASDAQ

2005IPO

About DEXCOM INC

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: DXCM
Employees: 11,100
IPO date: Apr 14, 2005
Headquarters: 6340 SEQUENCE DRIVE
SAN DIEGO, California 92121
Phone: (858) 200-0200
Industry: Medical Devices
Website: Visit site

Incorporation record

Incorporated in: DE, United States
Registered office: Wilmington, US
Legal entity ID: 549300YSK3QDSFR5EU59

Source: GLEIF, the global Legal Entity Identifier registry · checked Jul 26, 2026. A US headquarters does not always mean US incorporation.

Is Dexcom Inc an American company? Yes. Dexcom Inc is incorporated in Delaware, United States and headquartered in San Diego, California. Its legal-entity record reports no foreign parent — the company is independently American-owned.

Registry IDs

Ticker: DXCM Nasdaq
SEC CIK: 1093557
LEI: 549300YSK3QDSFR5EU59
EIN: 330857544
SIC: 3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Dexcom Inc’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/dexcom-inc/"><img src="https://americancompanies.com/badge/dexcom-inc.svg" alt="Dexcom Inc — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow DEXCOM INC and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $4.7B
Net income: $836.3M
Total assets: $6.3B
Market cap: $27.6B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: DXCM

$78.57 +0.81%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$54.84 $92.34

52-week range

Market cap: $27.6B
Shares outstanding: 351.3M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Apr 14, 2005

Dexcom Inc (DXCM) Stock Price

Profitable — net income of $836.3M in FY2025.
Trading 15% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

Peers & competitors

INSULET CORPPODD

Integer Holdings CorpITGR

ABBOTT LABORATORIESABT

HEALTHEQUITY, INC.HQY

AMN HEALTHCARE SERVICES INCAMN

No reviews yet. Be the first to review DEXCOM INC.

Write a review

Newsroom

News about DEXCOM INC

DexCom Gears Up to Report Q3 Results: How to Play the Stock? Zacks Investment Research · 2026-10-26 · neutral Global Digital Health and Remote Patient Monitoring Strategic Market Report, 2026-2031 | 20.2% CAGR to $80.8 Billion as Connected Care and Wearables Scale GlobeNewswire Inc. · 2026-10-21 · positive DexCom's G7 Shows Strong Results in Type 2 Diabetes CONNECT Study Zacks Investment Research · 2026-10-20 · positive Vaso Stock Surges 149% in a Year: What's Behind the Rally? Zacks Investment Research · 2026-10-16 · neutral Here's Why You Should Retain DexCom Stock in Your Portfolio for Now Zacks Investment Research · 2026-10-13 · neutral DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care Zacks Investment Research · 2026-10-02 · positive

News & sentiment via Polygon.io

FAQ

Dexcom Inc: frequently asked questions

Is Dexcom Inc an American company?

Yes — Dexcom Inc is an American company. Dexcom Inc is incorporated in Delaware, United States and headquartered in San Diego, California. Its legal-entity record reports no foreign parent — the company is independently American-owned.

Where is Dexcom Inc incorporated?

Dexcom Inc is legally incorporated in Delaware, United States, according to its GLEIF legal-entity record.

Who owns Dexcom Inc?

Dexcom Inc reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.

Is Dexcom Inc traded on a US stock exchange?

Yes — Dexcom Inc trades under the ticker DXCM on the NASDAQ.

Where is Dexcom Inc headquartered?

Dexcom Inc is headquartered in San Diego, California, United States.

Is Dexcom Inc publicly traded?

Yes — Dexcom Inc is a publicly traded company. Its stock trades under the ticker symbol DXCM on the NASDAQ.

What does Dexcom Inc do?

Dexcom Inc is an American Medical Devices company in the Health & Beauty sector.